185 related articles for article (PubMed ID: 15295615)
1. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.
Cordelier P; Kulkowsky JW; Ko C; Matskevitch AA; McKee HJ; Rossi JJ; Bouhamdan M; Pomerantz RJ; Kari G; Strayer DS
Gene Ther; 2004 Nov; 11(22):1627-37. PubMed ID: 15295615
[TBL] [Abstract][Full Text] [Related]
2. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
3. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.
di Marzio P; Mariani R; Lui R; Thomas EK; Landau NR
Cytokine; 2000 Oct; 12(10):1489-95. PubMed ID: 11023663
[TBL] [Abstract][Full Text] [Related]
6. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
Cordelier P; Morse B; Strayer DS
Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5.
Feng Y; Leavitt M; Tritz R; Duarte E; Kang D; Mamounas M; Gilles P; Wong-Staal F; Kennedy S; Merson J; Yu M; Barber JR
Virology; 2000 Oct; 276(2):271-8. PubMed ID: 11040119
[TBL] [Abstract][Full Text] [Related]
8. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
9. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
[TBL] [Abstract][Full Text] [Related]
11. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
[TBL] [Abstract][Full Text] [Related]
12. Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines.
Bai X; Chen JD; Yang AG; Torti F; Chen SY
Gene Ther; 1998 Jul; 5(7):984-94. PubMed ID: 9813670
[TBL] [Abstract][Full Text] [Related]
13. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J; Rossi J; Akkina R
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
Schroers R; Davis CM; Wagner HJ; Chen SY
Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
17. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
[TBL] [Abstract][Full Text] [Related]
19. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
20. The molecular cloning and functional expression of the dog CCR5.
Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
